The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Potnak, in agreement with your more mundane and logical approach. Puts the prospects in the right perspective.
Feet on the ground guys. We have a long long way to achieve that billion market cap and never a clear pathway as there will be hurdles to overcome. Happy to wait some years if it happens.
BYP -its called accountability and regretfully Novacyt lacks it big time. The DHSC dispute was conveniently minimised ans camouflaged with RNS's to build up SP momentum. Investors hoodwinked.
Point taken Abery. Not being negative at all. Its in my character not to be over exuberant . I am a holder of the shares and hold because i believe in the prospects. But you are well aware of the pitfalls of the sector. Will not moan if i lose money but will jump for joy if i do like everybody else.
I admire your resilience and optimism Potnak. You give good vibes. However feet firmly on the ground as there is never a smooth pathway to success. Delays may occur and regulatory health authorities might not be totally on board with the clinical trials.
Karen, all very logical reasoning and calculations. However our recent past experience suggests that nothing is " easily achievable". I am currently not a holder of Nova and have been for some months trying to see to which level the SP can go down to. Not confident that the company has got its act right and too many "ifs and but's" for my liking.
Well said Yellow. Different revenue streams needed if this company wants to go forward.
Thanks Soder. A refreshingly sober and objective analysis of the state of affairs. DHSC issue will remain a drag on the valuation until resolved.
HarChris i will appear whenever i feel i have to. Let me turn this round. You appear when the price is appreciating and this puts you in the ramper category. Subject closed have no time for petty people like you. Good luck
Hello HarChris Good morning. I will express MY OPINION whenever i feel the need to. I don't need any permission from the likes of you. Have a good day. stay safe.
Agree with you Kat. Price was certainly over inflated and together with lack of news is undermining the credibility in the company. If tox results are delayed further the SP will suffer. Hopefully this will not happen but no guarantees. I have already previously declared that i am a holder at an old price of 2p.
Fully justified in being disappointed.
MattyBoy, i beg to differ. Pfizer would not be interested at this stage in a company who have yet to produce tox results and who have not even started Phase 1 of the clinical trials. Prospects promising yes but the possibility of further delays following inconclusive results is still a possibility. We all know the risks----Galapagos-Orchard Therapetics-Tiziana Life Sciences just to mention a few examples. I am a holder at an average price of the old 2p. So yes disappointed but holding on and appreciate the risks with eyes wide open.
Good observation Basser
Obviously not. RNS wording does not indicate this at all. Patience is a virtue. let's wait till H2 for progress report.
just bought at 65.4. So really spread is fictitious. Good value.
Agree with your reasoning RBM. Future growth post Covid is the key.
Agree with your reasoning RBM. Future growth post Covid is the key.
i can assure you DRB 83 i am not new to the business and open minded enough to take criticism. I simply state my thought. Hope i do not need permission to do so.
Just thinking aloud-----is there a leak of info regarding toxicity............resulting in further delays?